Cargando…

Tissue Specific DNA Methylation in Normal Human Breast Epithelium and in Breast Cancer

Cancer is a heterogeneous and tissue-specific disease. Thus, the tissue of origin reflects on the natural history of the disease and dictates the therapeutic approach. It is suggested that tissue differentiation, mediated mostly by epigenetic modifications, could guide tissue-specific susceptibility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avraham, Ayelet, Cho, Sean Soonweng, Uhlmann, Ronit, Polak, Mia Leonov, Sandbank, Judith, Karni, Tami, Pappo, Itzhak, Halperin, Ruvit, Vaknin, Zvi, Sella, Avishay, Sukumar, Saraswati, Evron, Ella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961270/ https://www.ncbi.nlm.nih.gov/pubmed/24651077 http://dx.doi.org/10.1371/journal.pone.0091805

Ejemplares similares

Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells
por: Avraham, Ayelet, et al.
Publicado: (2020)

Mapping breast tissue types by miniature radio-frequency near-field spectroscopy sensor in ex-vivo freshly excised specimens
por: Kaufman, Zvi, et al.
Publicado: (2016)

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium
por: Han, Liangfeng, et al.
Publicado: (2021)

Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation
por: Barrio-Real, Laura, et al.
Publicado: (2014)

Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained
por: Ben David, Merav A., et al.
Publicado: (2021)

HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24
por: Teo, Wei Wen, et al.
Publicado: (2016)

Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer
por: Merino, Vanessa F., et al.
Publicado: (2018)

Inhibitors of STAT3, β‐catenin, and IGF‐1R sensitize mouse PIK3CA‐mutant breast cancer to PI3K inhibitors
por: Merino, Vanessa F., et al.
Publicado: (2017)

BRCA1: linking HOX to breast cancer suppression
por: Jin, Kideok, et al.
Publicado: (2010)

A pivotal role for HOXB7 protein in endocrine resistant breast cancer
por: Jin, Kideok, et al.
Publicado: (2015)

Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
por: Teo, Wei Wen, et al.
Publicado: (2014)

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
por: Fackler, Mary Jo, et al.
Publicado: (2020)

Ovarian Stem Cells—the Pros and Cons
por: Evron, Ayelet, et al.
Publicado: (2013)

Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic
por: Steinberg, Avraham, et al.
Publicado: (2020)

Human amniotic epithelial cells differentiate into cells expressing germ cell specific markers when cultured in medium containing serum substitute supplement
por: Evron, Ayelet, et al.
Publicado: (2012)

Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
por: Lee, Esak, et al.
Publicado: (2014)

Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
por: Koren, Ronit, et al.
Publicado: (2021)

Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic. Joint Commission of the Israel National Bioethics Council, the Ethics Bureau of the Israel Medical Association and Representatives from the Israeli Ministry of Health
por: Steinberg, Avraham, et al.
Publicado: (2020)

Editorial: Methods in genitourinary oncology
por: Jang, Albert, et al.
Publicado: (2023)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
por: Bernstein-Molho, Rinat, et al.
Publicado: (2022)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?
por: Cope, Leslie M., et al.
Publicado: (2014)

HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
por: Shah, Sandeep N., et al.
Publicado: (2013)

Somatic mutation and gain of copy number of PIK3CA in human breast cancer
por: Wu, Guojun, et al.
Publicado: (2005)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study
por: Wang, Guannan, et al.
Publicado: (2022)

Predetermined Flake Production at the Lower/Middle Paleolithic Boundary: Yabrudian Scraper-Blank Technology
por: Shimelmitz, Ron, et al.
Publicado: (2014)

Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing
por: Horvath, Anelia, et al.
Publicado: (2013)

Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
por: Parhi, Lishay, et al.
Publicado: (2020)

Treatment-Related Quality of Life in Nepalese Women with Breast Cancer
por: Bhandari, Saraswati, et al.
Publicado: (2017)

The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers
por: Strauss, Carmit, et al.
Publicado: (2014)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

Learning from the other limb's experience: sharing the ‘trained’ M1 representation of the motor sequence knowledge
por: Gabitov, Ella, et al.
Publicado: (2015)

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
por: Denys, Hannelore, et al.
Publicado: (2020)

MYC Gene Amplification is Often Acquired in Lethal Distant Breast Cancer Metastases of Unamplified Primary Tumors
por: Singhi, Aatur D., et al.
Publicado: (2011)

Attitudes of the Public to Receiving Medical Care during Emergencies through Remote Physician–Patient Communications
por: Hamlin, Matilda, et al.
Publicado: (2020)

Breast Cancer during Pregnancy—Current Paradigms, Paths to Explore
por: Alfasi, Ayelet, et al.
Publicado: (2019)

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection
por: de Groot, Jolien S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o7lhrpk68kr6angvftr67knps1